These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22747903)

  • 1. Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis.
    Van Deun A; Maug AK; Hossain A; Gumusboga M; de Jong BC
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1174-9. PubMed ID: 22747903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
    Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
    van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
    PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic dilemma: treatment outcomes of tuberculosis patients with inconsistent rifampicin susceptibility.
    Pang Y; Ruan YZ; Zhao J; Chen C; Xu CH; Su W; Huan ST; Li RZ; Zhao YL; Chin DP; Wang LX
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):357-62. PubMed ID: 24670576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China.
    Chen C; Kong W; Zhu L; Zhou Y; Peng H; Shao Y; Song H; Liu Q; Li G; Shi J; Zhong C; Zhu L; Ding X; Yu H; Yang H; Lu W
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1034-9. PubMed ID: 25189549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK; Holtz TH; Riekstina V; Leimane V
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout.
    Aung KJ; Declercq E; Ali MA; Naha S; Datta Roy SC; Taleb MA; Hossain MA; Rigouts L; Gumusboga A; Van Deun A
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):455-61. PubMed ID: 22640511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape.
    Albert H; Trollip AP; Seaman T; Abrahams C; Mole RJ; Jordaan A; Victor T; Hoosain E
    S Afr Med J; 2007 Sep; 97(9):858-63. PubMed ID: 17985057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple, direct drug susceptibility testing technique for diagnosis of drug-resistant tuberculosis in resource-poor settings.
    Kim CK; Joo YT; Lee EP; Park YK; Kim HJ; Kim SJ
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1212-6. PubMed ID: 23823178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and early detection of Mycobacterium tuberculosis complex and rifampicin resistance from sputum smears.
    Bhutia R; Narain K; Devi KR; Singh TS; Mahanta J
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):258-61. PubMed ID: 23317964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
    Khalil KF; Butt T
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.
    Morcillo N; Zumarraga M; Alito A; Dolmann A; Schouls L; Cataldi A; Kremer K; van Soolingen D
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):959-65. PubMed ID: 12475141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes.
    Katende B; Esterhuizen TM; Dippenaar A; Warren RM
    Sci Rep; 2020 Feb; 10(1):1917. PubMed ID: 32024860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
    Qi W; Harries AD; Hinderaker SG
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon.
    Noeske J; Voelz N; Fon E; Abena Foe JL
    BMC Res Notes; 2012 Mar; 5():160. PubMed ID: 22436423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS; Kumar AM; Claassens M; Banurekha VV; Sekar G; Venkatesan P; Swaminathan S
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Jain A; Singh PK; Singh U; Kumar V
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):478-480. PubMed ID: 28284274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.